{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:05:29Z","timestamp":1789103129997,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":227,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.04.104","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T00:01:22Z","timestamp":1337212882000},"page":"3-11","source":"Crossref","is-referenced-by-count":71,"title":["Long-term protective effects of hepatitis A vaccines. A systematic review"],"prefix":"10.1016","volume":"31","author":[{"given":"J\u00f6rdis Jennifer","family":"Ott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Todd","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.04.104_bib0005","unstructured":"Rein D. Modeling the global burden of hepatitis A virus infections in 1990 and 2005. Poster presentation at the Liver Meeting, 2011 http:\/\/liverlearning.aasld.org\/aasld\/2011\/thelivermeeting\/14085\/doctor.david.rein.modeling.the.global.burden.of.hepatitis.a.virus.infections.html, [accessed 02.03.12]."},{"key":"10.1016\/j.vaccine.2012.04.104_bib0010","first-page":"38","article-title":"Hepatitis A vaccines: WHO position paper","volume":"75","author":"WHO","year":"2000","journal-title":"Weekly Epidemiological Record"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0015","series-title":"Viral Hepatitis","article-title":"Natural history and experimental models","author":"Purcell","year":"2005"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0020","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","article-title":"Hepatitis A virus seroprevalence by age and world region, 1990 and 2005","volume":"28","author":"Jacobsen","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.104_bib0025","article-title":"Hepatitis A immunisation in persons not previously exposed to hepatitis A","author":"Irving","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0030","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1994.03510410040030","article-title":"Protection against hepatitis A by an inactivated vaccine","volume":"271","author":"Innis","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199208133270702","article-title":"A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children","volume":"327","author":"Werzberger","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<1::AID-JMV1>3.0.CO;2-H","article-title":"Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines","volume":"60","author":"Van Herck","year":"2000","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1096-9071(200101)63:1<1::AID-JMV1000>3.0.CO;2-U","article-title":"Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence","volume":"63","author":"Van Herck","year":"2001","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jmv.10574","article-title":"Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course","volume":"72","author":"Van Herck","year":"2004","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0055","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0264-410X(96)00242-3","article-title":"Inactivated hepatitis A vaccine: long-term antibody persistence","volume":"15","author":"Wiedermann","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<235::AID-JMV13>3.0.CO;2-B","article-title":"Duration of protection from clinical hepatitis A disease after vaccination with VAQTA","volume":"49","author":"Wiens","year":"1996","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0065","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jmv.21883","article-title":"Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine","volume":"82","author":"Bovier","year":"2010","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0070","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","article-title":"International consensus group on hepatitis A virus immunity. Hepatitis A booster vaccination: is there a need?","volume":"362","author":"Van Damme","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/00365540110077362","article-title":"Excellent booster response 4\u20136 y after a single primary dose of an inactivated hepatitis A vaccine","volume":"34","author":"Iwarson","year":"2002","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0264-410X(00)00188-2","article-title":"Inactivated hepatitis A vaccine booster given \u226524 months after the primary dose","volume":"19","author":"Landry","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0264-410X(99)00342-4","article-title":"Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine","volume":"18","author":"Cederna","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0090","first-page":"111","article-title":"Immunogenicity and long-term persistence of anti-HAV in groups with different attenuated and inactived hepatitis A vaccine dosage","volume":"22","author":"Wang","year":"2001","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0264-410X(98)00200-X","article-title":"Long-term follow-up of hepatitis A vaccination in children","volume":"17","author":"Chan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0264-410X(97)00179-5","article-title":"Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years","volume":"16","author":"Fan","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0264-410X(97)00211-9","article-title":"Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine","volume":"15","author":"Maiwald","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0110","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0264-410X(97)00022-4","article-title":"Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination","volume":"15","author":"Totos","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/INF.0b013e3181d57a85","article-title":"Long-term immunity after two doses of inactivated hepatitis A vaccine, in Argentinean children","volume":"29","author":"Lopez","year":"2010","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0120","first-page":"321","article-title":"Long-term immunogenicity of inactivated hepatitis A vaccine: Follow-up at 15 years","volume":"5","author":"Byrd","year":"2010","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0125","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.vaccine.2004.11.024","article-title":"Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine","volume":"23","author":"Bovier","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0130","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/infdis\/jir180","article-title":"Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults","volume":"203","author":"Crum-Cianflone","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0135","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1016\/j.vaccine.2010.04.096","article-title":"Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children","volume":"28","author":"Bian","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0140","first-page":"1851","article-title":"Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program","volume":"118","author":"Zhuang","year":"2005","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0145","first-page":"1332","article-title":"Long-term immunogencity and effectiveness of live attenuated hepatitis A vaccine (H2-strain) \u2013 a study on the result of 15 years\u2019 follow up","volume":"31","author":"Zhuang","year":"2010","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0150","first-page":"180","article-title":"The immunological effects of three doses of a live attenuated hepatitis A vaccine (H2 strain) in 8 years","volume":"23","author":"Liu","year":"2009","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0155","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.vaccine.2006.08.004","article-title":"Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0160","first-page":"300","article-title":"Comparison of antibody persistence between live attenuated and inactivated hepatitis A vaccines","volume":"15","author":"Liu","year":"2009","journal-title":"Zhongguo Yi Miao He Mian Yi"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0165","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/QAI.0b013e31821fdec3","article-title":"Long-term persistence of humoral immunity after hepatitis A vaccination in HIV-infected adults","volume":"57","author":"Kern\u00e9is","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0170","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/sim.1291","article-title":"Publishing research from developing countries","volume":"21","author":"Smith","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0175","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/0264-410X(92)90572-2","article-title":"Inactivated hepatitis A vaccine: active and passive immuno-prophylaxis in chimpanzees","volume":"10","author":"Purcell","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0180","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/148.6.1033","article-title":"Serum neutralizing antibody response to hepatitis A virus","volume":"148","author":"Lemon","year":"1983","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1590\/S1020-49892007000500002","article-title":"Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted","volume":"21","author":"Ellis","year":"2007","journal-title":"Revista Panamericana de Salud Publica"},{"key":"10.1016\/j.vaccine.2012.04.104_bib0190","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/peds.2006-1572","article-title":"The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity","volume":"119","author":"Armstrong","year":"2007","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T15:31:54Z","timestamp":1642260714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12006731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0264410X12006731"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}